免疫抑制药物环素A在CD8+ T细胞中具有免疫刺激功能
Jannis Wißfeld1,2, Marvin Hering1,2,3,4,5, Nora Ten Bosch1,2
1Helmholtz Institute for Translational Oncology (HI-TRON) Mainz, Mainz, Germany.
European journal of immunology
|April 22, 2024
概括
环素A通过激活mTORC1通路来意外地刺激T细胞,这与其已知的免疫抑制作用相反. 结合氨酸和mTORC1抑制可以提高T细胞白血病的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 环素A (CsA) 是一种广泛使用的免疫抑制剂.
- 它通过抑制氨酸-NFAT信号传递来起作用,这对于T细胞激活至关重要.
- 除了氨酸抑制之外,CsA在T细胞代谢和激活中的作用不太清楚.
研究的目的:
- 为了调查环素A的意想不到的免疫刺激作用.
- 阐明CsA影响T细胞激活的机制.
- 探索针对氨酸-NFAT和mTORC1通路的组合疗法.
主要方法:
- 选工具的化合物调节mTORC1的激活.
- 评估mTORC1在CD8+T细胞中的激活.
- 研究PDK1和PKB/AKT信号的作用.
- 评估CsA与mTORC1抑制剂的协同效应.
主要成果:
- 环素A出乎意料地激活了CD8+ T细胞中的猛素复合体1 (mTORC1) 的哺乳动物点.
- 这种激活取决于3酸依赖蛋白激酶1 (PDK1) 和蛋白激酶B (PKB/AKT).
- CsA通过抑制氨酸介导的AKT脱化来稳定mTORC1信号,与mTORC1抑制剂协同,抑制T细胞增殖和细胞因子的产生.
结论:
- 环素A具有双重作用,抑制氨酸-NFAT,同时刺激T细胞中的mTORC1信号传递.
- 同时针对氨酸-NFAT和mTORC1通路对于最大限度地提高治疗效果至关重要.
- 这种双重向策略对治疗T细胞白血病和其他相关疾病具有前景.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
160
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
160
Cytotoxic T Cells-mediated Immune Response
903
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
903
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
T Cell Activation and Clonal Selection
714
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
714
Cell-mediated Immune Responses
68.2K
Overview
68.2K
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520


